OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing

MT Newswires Live
06/11

OraSure Technologies (OSUR) has received US Food and Drug Administration clearance for its Colli-Pee Dx Urine Collection Kit for use with Roche molecular tests for chlamydia, gonorrhea, trichomoniasis and mycoplasma genitalium, the company said Thursday.

The clearance allows patients to self-collect urine samples at home or in other private settings for testing on Roche's molecular diagnostic systems, OraSure said.

The company said the kit uses its NucleoPrecision technology to stabilize DNA and RNA and maintain sample integrity at ambient temperatures.

Shares of the company were over 3% higher in Thursday premarket trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10